Nordic Nanovector to Amend PARADIGME Trial Protocol to Expand Eligible Patient Population

Corporate Breaking News

Home : Nordic Nanovector to Amend PARADIGME Trial Protocol to Expand Eligible Patient Population

Jun 30 2020	Nordic Nanovector to Amend PARADIGME Trial Protocol to Expand Eligible Patient Population
OSLO, Norway, June 30, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that it will amend the trial protocol for its PARADIGME trial to broaden the inclusion criteria and expand the pool of eligible patients with the aim of increasing the present rate of enrolment. This...


Source:https://www.prnewswire.com:443/news-releases/nordic-nanovector-to-amend-paradigme-trial-protocol-to-expand-eligible-patient-population-301085578.html

Related News
» US Updates Toy and Childcare Product Rules to Exempt Some Fibers from Third Party Testing » Toyobo, 11 other companies jointly launch R Plus Japan, Ltd. to recycle used plastics